| CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
| 137061-48-4 | 腺苷酸环化酶激活肽-38(抗原) | H-HIS-SER-ASP-GLY-Ile-PHE-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-LYS-GLN-MET-Ala-VAL-LYS-LYS-TYR-LEU-Ala-AL; H-HIS-SER-ASP-GLY-Ile-PHE-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-LYS-GLN-MET-Ala-VAL-LYS-LYS-TYR-LEU-Ala-Ala-VAL-LEU-GLY-LYS-Arg-TYR-LYS-GLN-Arg-VAL-LYS-ASN-LYS-NH2; HIS-SER-ASP-GLY-Ile-PHE-THR-ASP-SER-TYR-SER-Arg-TYR-Arg-LYS-GLN-MET-Ala-VAL-LYS-LYS-TYR-LEU-Ala-Ala-VAL-LEU-GLY-LYS-Arg-TYR-LYS-GLN-Arg-VAL-LYS-ASN-LYS-NH2; HSDGIFTDSYSRYRKQMAVKKYLAAVLGKRYKQRVKNK-NH2; ADENYLATE CYCLASE ACTIVATING PEPTIDE-38; ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-38; PACAP (1-38), AMIDE, HUMAN, OVINE, RAT; PACAP (1-38), HUMAN, OVINE, RAT; PACAP (1-38) (HUMAN, SHEEP, RAT) | 无 | C203H331N63O53S1 | 详情 | 供应商 |
| 81156-93-6 | Arg-Arg-LEU-Ile-GLU-ASP-Ala-GLU-TYR-Ala-Ala-Arg-GLY | Arg-Arg-LEU-Ile-GLU-ASP-Ala-GLU-TYR-Ala-Ala-Arg-GLY; H-Arg-Arg-LEU-Ile-GLU-ASP-Ala-GLU-TYR-Ala-Ala-Arg-GLY-OH; INSULIN RECEPTOR/TYROSINE KINASE SUBSTRATE; Arg-Arg-LEU-Ile-GLU-ASP-Ala-GLU-TYR-Ala-Ala-Arg-GLY; RRLIEDAEYAArg; RR-SRC; R-R-SRC-PEPTIDE; TYROSINE KINASE PEPTIDE 3 [RRLIEDAEYAArg]; TYROSINE KINASE SUBSTRATE RR-SRC | ![]() | C64H106N22O21 | 详情 | 供应商 |
| 81493-98-3 | 酪氨酸激酶 | H-Arg-Arg-LEU-Ile-GLU-ASP-ASN-GLU-TYR-THR-Ala-Arg-GLY-OH; Arg-Arg-LEU-Ile-GLU-ASP-ASN-GLU-TYR-THR-Ala-Arg-GLY; H-Arg-Arg-LEU-Ile-GLU-ASP-ASN-GLU-TYR-THR-Ala-Arg-GLY-OH; TYROSINE KINASE SUBSTRATE; RRLIEDNEYTArg; PP60(V-SRC) AUTOPHOSPHORYLATION SITE; PP60V-SRC FRAGMENT; Arg-Arg-leu-Ile-glu-asp-asn-glu-tyr-*thr-Ala-Arg-; TYROSINE KINASE SUBSTRATE SYNTHETIC >96% | ![]() | C66H109N23O23 | 详情 | 供应商 |
| 90984-99-9 | Arg-Arg-SER-SER-CYS-PHE-GLY-GLY-Arg-Ile-ASP-Arg-Ile-GLY-Ala-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-Arg- | Arg-Arg-SER-SER-CYS-PHE-GLY-GLY-Arg-Ile-ASP-Arg-Ile-GLY-Ala-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-Arg-; H-Arg-Arg-SER-SER-CYS-PHE-GLY-GLY-Arg-Ile-ASP-Arg-Ile-GLY-Ala-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-Arg-TYR-OH; ATRIAL NATRIURETIC PEPTIDE RAT FRAGMENT 3-28; ATRIAL NATRIURETIC FACTOR (3-28) (RAT); ATRIAL NATRIURETIC PEPTIDE (3-28), RAT; A-TYPE (ATRIAL) NATRIURETIC PEPTIDE (RAT, 3-28); Arg-Arg-SER-SER-CYS-PHE-GLY-GLY-Arg-Ile-ASP-Arg-Ile-GLY-Ala-GLN-SER-GLY-LEU-GLY-CYS-ASN-SER-PHE-Arg-TYR; ANP (RAT, 3-28); ANP (3-28), RAT | ![]() | C119H189N43O36S2 | 详情 | 供应商 |
| 113873-67-9 | 神经储钙蛋白基质 | ASP-LEU-ASP-VAL-PRO-Ile-PRO-GLY-Arg-PHE-ASP-Arg-Arg-VAL-SER-VAL-Ala-Ala-GLU; ASP-LEU-ASP-VAL-PRO-Ile-PRO-GLY-Arg-PHE-ASP-Arg-Arg-VAL-SER-VAL-Ala-Ala-GLU; DLDVPIPGRFDRRVSVAAE; CALCINEURIN (PP2B) SUBSTRATE [DLDVPIPGRFDRRVSSVAAE], NON-PHOSPHORYLATED; CALCINEURIN SUBSTRATE; H-ASP-LEU-ASP-VAL-PRO-Ile-PRO-GLY-Arg-PHE-ASP-Arg-Arg-VAL-SER-VAL-Ala-Ala-GLU-OH; [Ala-97]-RII (81-99); Calcineurin (PP2B) Substrate [DLDVPIPGRFDRRVSVAAE], Non-Phosphorylated | ![]() | C92H150N28O29 | 详情 | 供应商 |
| 63014-08-4 | DNP-PRO-GLN-GLY-Ile-Ala-GLY-GLN-D-Arg | DNP-PRO-GLN-GLY-Ile-Ala-GLY-GLN-D-Arg-OH; DNP-PRO-GLN-GLY-Ile-Ala-GLY-GLN-D-Arg; DNP-PRO-GLN-GLY-Ile-Ala-GLY-GLN-D-Arg-OH; DNP-PQGIAGQ-D-R; COLLAGENASE SUBSTRATE I; 2,4-DINITROPHENYL-L-PROLYL-L-GLUTAMINYLGLYCYL-L-ISOLEUCYL-L-AlaNYLGLYCYL-L-GLUTAMINYL-D-ArgININE; 2,4-DINITROPHENYL-PRO-GLN-GLY-Ile-Ala-GLY-GLN-D-Arg-OH; N2-[N2-[N-[N-[N-[N-[N2-[1-(2,4-dinitrophenyl)-L-prolyl]-L-glutaminyl]glycyl]-L-isoleucyl]-L-Alanyl]glycyl]-L-glutaminyl]-D-Arginine; DNP-peptide | ![]() | C40H61N15O15 | 详情 | 供应商 |
| 81117-26-2 | H-LYS-Arg-ASN-LYS-ASN-ASN-Ile-Ala-OH | H-LYS-Arg-ASN-LYS-ASN-ASN-Ile-Ala-OH; GLUCAGON FRAGMENT 30-37; H-LYS-Arg-ASN-LYS-ASN-ASN-Ile-Ala-OH; glucagon 37 fragment 30-37; glicentin (62-69) | ![]() | C39H72N16O12 | 详情 | 供应商 |
| 198694-74-5 | H-LYS-Arg-Arg-TRP-LYS-LYS-ASN-PHE-Ile-Ala-VAL-NH2; MYOSIN LIGHT CHAIN KINASE INHIBITOR; MYOSIN LIGHT CHAIN KINASE (342-352) AMIDE; MLCK INHIBITOR PEPTIDE; H-LYS-Arg-Arg-TRP-LYS-LYS-ASN-PHE-Ile-Ala-VAL-NH2; LYS-Arg-Arg-TRP-LYS-LYS-ASN-PHE-Ile-Ala-VAL-NH2 | ![]() | C68H113N23O12 | 详情 | 供应商 | |
| 843782-19-4 | LEU-PRO-Arg-LEU-LEU-HIS-THR-ASP-SER-Arg-MET-Ala-THR-Ile-ASP-PHE-PRO-LYS-LYS-ASP-PRO-THR-THR-SER-LEU- | H-LEU-PRO-Arg-LEU-LEU-HIS-THR-ASP-SER-Arg-MET-Ala-THR-Ile-ASP-PHE-PRO-LYS-LYS-ASP-PRO-THR-THR-SER-LE; H-LEU-PRO-Arg-LEU-LEU-HIS-THR-ASP-SER-Arg-MET-Ala-THR-Ile-ASP-PHE-PRO-LYS-LYS-ASP-PRO-THR-THR-SER-LEU-GLY-Arg-PRO-PHE-PHE-LEU-PHE-Arg-PRO-Arg-ASN-NH2; NEUROMEDIN S (RAT); NMS (RAT) | 无 | C193H307N57O49S | 详情 | 供应商 |
| 197230-90-3 | ACETYL-NEUROTROPHIN RECEPTOR (368-381) AMIDE (HUMAN) | AC-Ala-THR-LEU-ASP-Ala-LEU-LEU-Ala-Ala-LEU-Arg-Arg-Ile-GLN-NH2; NTR 368; AC-Ala-THR-LEU-ASP-Ala-LEU-LEU-Ala-Ala-LEU-Arg-Arg-Ile-GLN-NH2; ACETYL-NEUROTROPHIN RECEPTOR (365-378) AMIDE (RAT); ACETYL-NEUROTROPHIN RECEPTOR (368-381) AMIDE (HUMAN); AC-NEUROTROPHIN RECEPTOR (368-381) AMIDE (HUMAN); Neurotrophin receptor (368-381) amide; M.W. 1565.86 C69H124N22O19 | ![]() | C69H124N22O19 | 详情 | 供应商 |
| 53935-10-7 | SAR-Arg-VAL-TYR-Ile-HIS-PRO-Ala ACETATE SALT; [SAR1,Ala 8]-ANGIOTENSIN II ACETATE SALT; SAR-Arg-VAL-TYR-Ile-HIS-PRO-Ala ACETATE SALT; (sar1,Ala8)-angiotensin ii acetate | ![]() | C45H71N13O12 | 详情 | 供应商 | |
| 112955-31-4 | Ala-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS- | Ala-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-; PTH-RP (HUMAN, 1-34 AMIDE) (RAT, MOUSE); PARATHYROID HORMONE RELATED PROTEIN (HUMAN, 1-34 AMIDE) (RAT, MOUSE); Ala-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-Ile-HIS-THR-Ala-NH2; HYPERCALCEMIA OF MALIGNANCY FACTOR*FRAGM ENT 1-34 AM; Ala-val-ser-glu-his-gln-leu-leu-his-asp-lys-gly-lys-ser-Ile-gln-asp-leu-Arg-Arg-Arg-phe-phe-leu-his-his-leu-Ile-Ala-glu-Ile-his-thr-Ala-nh2; Parathyroid hormone-related protein (1-34) Amide, PTHrP (1-34) amide, Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2; Humoral Hypercalcemic Factor (hHCF)(1-34)-NH2 (Human) | 无 | C180H288N58O47 | 详情 | 供应商 |
| 98264-90-5 | TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-Ala-PRO-Ala-GLU-ASP-MET-Ala-Arg-TYR-TYR-SER-Ala-LEU-Arg- | H-Ala-Arg-TYR-TYR-SER-Ala-LEU-Arg-HIS-TYR-Ile-ASN-LEU-Ile-THR-Arg-GLN-Arg-TYR-NH2; Ala-Arg-TYR-TYR-SER-Ala-LEU-Arg-HIS-TYR-Ile-ASN-LEU-Ile-THR-Arg-GLN-Arg-TYR-NH2; ARYYSALRHYINLITRQRY-NH2; H-Ala-Arg-TYR-TYR-SER-Ala-LEU-Arg-HIS-TYR-Ile-ASN-LEU-Ile-THR-Arg-GLN-Arg-TYR-NH2; NEUROPEPTIDE Y (18-36); NEUROPEPTIDE Y(18-36), PORCINE; NEUROPEPTIDE Y FRAGMENT 18-36 HUMAN, PORCINE; NPY (18-36); NPY(18-36) PORCINE | ![]() | C112H174N36O27 | 详情 | 供应商 |
| 99534-03-9 | THR-THR-TYR-Ala-ASP-PHE-Ile-Ala-SER-GLY-Arg-THR-GLY-Arg-Arg-ASN-Ala-Ile-HIS-ASP; THR-THR-TYR-Ala-ASP- | H-THR-THR-TYR-Ala-ASP-PHE-Ile-Ala-SER-GLY-Arg-THR-GLY-Arg-Arg-ASN-Ala-Ile-HIS-ASP-OH; H-TTYADFIASGRTGRRNAIHD; H-THR-THR-TYR-Ala-ASP-PHE-Ile-Ala-SER-GLY-Arg-THR-GLY-Arg-Arg-ASN-Ala-Ile-HIS-ASP-OH; CAMP DEPENDENT PK INHIBITOR (5-24); CAMP-DEPENDENT PROTEIN KINASE INHIBITOR (5-24); CAMP-DEPENDENT PROTEIN KINASE INHIBITOR-ALPHA (5-24) (HUMAN, MOUSE, RABBIT, RAT); ip20; TTYADFIASGRTGRRNAIHD; THR-THR-TYR-Ala-ASP-PHE-Ile-Ala-SER-GLY-Arg-THR-GLY-Arg-Arg-ASN-Ala-Ile-HIS-ASP | ![]() | C94H148N32O31 | 详情 | 供应商 |
| 92915-79-2 | Ile-SER-GLN-Ala-VAL-HIS-Ala-Ala-HIS-Ala-GLU-Ile-ASN-GLU-Ala-GLY-Arg | H-Ile-SER-GLN-Ala-VAL-HIS-Ala-Ala-HIS-Ala-GLU-Ile-ASN-GLU-Ala-GLY-Arg-OH; OVALBUMIN CHICKEN (323-339); OVALBUMIN (323-339) (CHICKEN, JAPANESE QUAIL); OVA (323-339); OVA (323-339) (CHICKEN, JAPANESE QUAIL); H2N-ISQAVHAAHAEINEAGR-OH; Ile-SER-GLN-Ala-VAL-HIS-Ala-Ala-HIS-Ala-GLU-Ile-ASN-GLU-Ala-GLY-Arg; H-Ile-SER-GLN-Ala-VAL-HIS-Ala-Ala-HIS-Ala-GLU-Ile-ASN-GLU-Ala-GLY-Arg-OH; ISQAVHAAHAEINEAGR | ![]() | C74H120N26O25 | 详情 | 供应商 |
| 112540-82-6 | Ala-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-Ile-HIS-THR-Ala; Ala-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-Ile-HIS-THR-Ala; Ala-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-Ile-HIS-THR-Ala-NH2: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; Ala-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-Ile-HIS-THR-Ala: AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA | H-Ala-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-Ile-HIS-THR-Ala-OH; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA; AVSEHQLLHDKGKSIQDLRRRFFLHHLIAEIHTA-NH2; H-Ala-VAL-SER-GLU-HIS-GLN-LEU-LEU-HIS-ASP-LYS-GLY-LYS-SER-Ile-GLN-ASP-LEU-Arg-Arg-Arg-PHE-PHE-LEU-HIS-HIS-LEU-Ile-Ala-GLU-Ile-HIS-THR-Ala-OH; HUMORAL HYPERCALCEMIA OF MALIGNANCY FACTOR, (1-34), HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) AMIDE (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) HUMAN; HYPERCALCEMIA OF MALIGNANCY FACTOR (1-34) (HUMAN, RAT); HYPERCALCEMIA OF MALIGNANCY FACTOR FRAGMENT 1-34 AMIDE HUMAN | 无 | C180H287N57O48 | 详情 | 供应商 |
| 17998-69-5 | H-Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | 无 | 详情 | 供应商 |